Apyx Medical Co. (NASDAQ:APYX) Short Interest Update

Apyx Medical Co. (NASDAQ:APYX) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 247,300 shares, a growth of 71.0% from the March 31st total of 144,600 shares. Approximately 0.8% of the company’s stock are sold short. Based on an average daily volume of 45,800 shares, the short-interest ratio is currently 5.4 days.

Apyx Medical Stock Performance

Shares of APYX opened at $0.94 on Wednesday. The company has a quick ratio of 4.52, a current ratio of 5.46 and a debt-to-equity ratio of 3.03. The stock has a market cap of $35.53 million, a P/E ratio of -1.13 and a beta of 0.92. The business’s 50 day moving average price is $1.12 and its 200-day moving average price is $1.34. Apyx Medical has a 52 week low of $0.76 and a 52 week high of $1.99.

Apyx Medical (NASDAQ:APYX) last released its earnings results on Thursday, March 13th. The company reported ($0.12) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.01. Apyx Medical had a negative return on equity of 137.98% and a negative net margin of 58.59%. The business had revenue of $14.22 million for the quarter, compared to the consensus estimate of $13.39 million. Equities research analysts anticipate that Apyx Medical will post -0.68 earnings per share for the current fiscal year.

Institutional Trading of Apyx Medical

Several institutional investors have recently bought and sold shares of the company. Nantahala Capital Management LLC bought a new position in shares of Apyx Medical in the fourth quarter worth approximately $5,008,000. Archon Capital Management LLC raised its holdings in Apyx Medical by 0.8% in the 4th quarter. Archon Capital Management LLC now owns 3,140,281 shares of the company’s stock worth $4,962,000 after acquiring an additional 25,000 shares during the last quarter. Royce & Associates LP lifted its position in Apyx Medical by 1.3% in the 4th quarter. Royce & Associates LP now owns 2,615,369 shares of the company’s stock valued at $4,132,000 after acquiring an additional 32,879 shares in the last quarter. Silverberg Bernstein Capital Management LLC boosted its stake in Apyx Medical by 13.2% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 646,569 shares of the company’s stock valued at $886,000 after purchasing an additional 75,337 shares during the last quarter. Finally, Commonwealth Equity Services LLC increased its holdings in shares of Apyx Medical by 3.0% in the 4th quarter. Commonwealth Equity Services LLC now owns 527,061 shares of the company’s stock worth $833,000 after purchasing an additional 15,500 shares in the last quarter. 55.33% of the stock is owned by hedge funds and other institutional investors.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.